Correlation Between 00108WAF7 and Unicycive Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both 00108WAF7 and Unicycive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 00108WAF7 and Unicycive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AEP TEX INC and Unicycive Therapeutics, you can compare the effects of market volatilities on 00108WAF7 and Unicycive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 00108WAF7 with a short position of Unicycive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 00108WAF7 and Unicycive Therapeutics.

Diversification Opportunities for 00108WAF7 and Unicycive Therapeutics

-0.01
  Correlation Coefficient

Good diversification

The 3 months correlation between 00108WAF7 and Unicycive is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding AEP TEX INC and Unicycive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unicycive Therapeutics and 00108WAF7 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AEP TEX INC are associated (or correlated) with Unicycive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unicycive Therapeutics has no effect on the direction of 00108WAF7 i.e., 00108WAF7 and Unicycive Therapeutics go up and down completely randomly.

Pair Corralation between 00108WAF7 and Unicycive Therapeutics

Assuming the 90 days trading horizon AEP TEX INC is expected to generate 11.34 times more return on investment than Unicycive Therapeutics. However, 00108WAF7 is 11.34 times more volatile than Unicycive Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Unicycive Therapeutics is currently generating about 0.02 per unit of risk. If you would invest  7,585  in AEP TEX INC on September 24, 2024 and sell it today you would earn a total of  83.00  from holding AEP TEX INC or generate 1.09% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy69.48%
ValuesDaily Returns

AEP TEX INC  vs.  Unicycive Therapeutics

 Performance 
       Timeline  
AEP TEX INC 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in AEP TEX INC are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, 00108WAF7 sustained solid returns over the last few months and may actually be approaching a breakup point.
Unicycive Therapeutics 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Unicycive Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady fundamental indicators, Unicycive Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

00108WAF7 and Unicycive Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with 00108WAF7 and Unicycive Therapeutics

The main advantage of trading using opposite 00108WAF7 and Unicycive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 00108WAF7 position performs unexpectedly, Unicycive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unicycive Therapeutics will offset losses from the drop in Unicycive Therapeutics' long position.
The idea behind AEP TEX INC and Unicycive Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Global Correlations
Find global opportunities by holding instruments from different markets